Despite Dividend Cut, Exelon Still Has Wide Moat
The energy firm's narrowed dividend was within the range of Morningstar's Travis Miller's expectations, but Exelon still faces near-term challenges.
The energy firm's narrowed dividend was within the range of Morningstar's Travis Miller's expectations, but Exelon still faces near-term challenges.
Exelon (EXC) management announced Thursday, along with its 2013 earnings results, that it plans to cut its dividend to a $1.24-per-share annualized rate starting with its second-quarter 2013 payment. This does not affect our fair value estimate or wide-moat rating. Full-year results were in line with our expectations, and we are reaffirming our fair value estimate and moat rating.
The dividend cut is between the target $1.50 per share we had expected and the worst-case $1.00 per share we estimated. At Exelon's closing price Wednesday, the new annualized rate implies a 4% yield. Shareholders will receive one more quarterly payment of $0.525 per share, payable March 8.
Exelon's full-year adjusted earnings per share were $2.85, in line with our estimate but 31% lower than 2011 results primarily because of lower earnings at the Exelon Generation subsidiary. Lower wholesale generation margins and higher costs sank Exelon Generation's earnings to $283 million in the fourth quarter, down 21% year over year. Exelon Generation's nuclear fleet continues to operate at an industry-leading level, achieving a 93% capacity factor across its fleet. A favorable regulatory ruling in Illinois boosted ComEd's revenue by $135 million.
Management introduced its 2013 EPS forecast of $2.35-$2.65. This is in line with our 2013 EPS estimate of $2.50. We continue to expect trough EPS in 2014 at $2.26. Management hedged another 10% of its expected 2014 expected generation but just about 8% of 2015 expected generation since November. Exelon now has hedged just about 30% of its 2015 expected generation, leaving a bit larger open position than it typically would carry to capture the potential upside we think will develop in the coming year.
Morningstar Premium Members gain exclusive access to our full Exelon Analyst Report, including fair value estimate, consider buying/selling prices, bull and bear breakdowns, and risk analysis. Not a Premium member? Get these reports immediately when you try Morningstar Premium free for 14 days.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals
and individual investors. These products and services are usually sold through
license agreements or subscriptions. Our investment management business generates
asset-based fees, which are calculated as a percentage of assets under management.
We also sell both admissions and sponsorship packages for our investment conferences
and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.